@article {7770,
	title = {High levels of serum angiogenic growth factors in patients with AL amyloidosis: Comparisons with normal individuals and multiple myeloma patients},
	journal = {British Journal of Haematology},
	volume = {150},
	year = {2010},
	note = {Cited By :7Export Date: 21 February 2017},
	month = {2010},
	pages = {587 - 591},
	abstract = {Summary Serum levels of five angiogenic cytokines were evaluated in 82 patients with primary systemic amyloidosis (AL). Angiopoietin-1, vascular endothelial growth factor, basic fibroblast growth factor and angiogenin were higher in AL patients than in controls (n = 35) and newly-diagnosed, symptomatic, myeloma patients (n = 35). Angiopoetin-1/Angiopoetin-2 ratio was lower in AL compared to controls but higher than in myeloma patients. Angiopoetin-2 correlated with cardiac dysfunction indices; however, none of the angiogenic growth factors was prognostically significant. The increased angiogenic cytokine levels observed in AL seem to represent either a toxic effect of amyloid fibrils or light chains, or a compensatory response to organ dysfunction. {\textcopyright} 2010 Blackwell Publishing Ltd.},
	keywords = {amyloidosis, Angiogenesis, angiopoietin, myeloma, Vascular endothelial growth factor},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955817597\&doi=10.1111\%2fj.1365-2141.2010.08288.x\&partnerID=40\&md5=cbb54fa49d8b6db26fb8df751be05607},
	author = {Kastritis, E. and Roussou, M. and Michael, M. and Gavriatopoulou, M. and Michalis, E. and Migkou, M. and Delimpasi, S. and Kyrtsonis, M.C. and Gogos, D. and Liapis, K. and Charitaki, E. and Repousis, P. and Terpos, E. and Dimopoulos, M.A.}
}
